1. Home
  2. SMTI vs RZLT Comparison

SMTI vs RZLT Comparison

Compare SMTI & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$35.15

Market Cap

313.5M

Sector

Health Care

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.79

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
RZLT
Founded
1982
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
313.5M
420.8M
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
SMTI
RZLT
Price
$35.15
$3.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$34.00
$9.67
AVG Volume (30 Days)
246.4K
1.2M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
$15,586,976.00
N/A
Revenue This Year
$17.31
N/A
Revenue Next Year
$12.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.47
N/A
52 Week Low
$16.05
$1.07
52 Week High
$35.27
$11.46

Technical Indicators

Market Signals
Indicator
SMTI
RZLT
Relative Strength Index (RSI) 74.06 29.46
Support Level $33.99 $3.71
Resistance Level N/A $3.98
Average True Range (ATR) 0.24 0.25
MACD -0.21 -0.07
Stochastic Oscillator 75.38 11.96

Price Performance

Historical Comparison
SMTI
RZLT

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: